No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Rigel Pharmaceuticals Gets FDA Orphan-Drug Designation for R289
Express News | Rigel Announces R289 Granted Orphan Drug Designation by the FDA for Mds
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)